Weekly updateCompaniesRecruiting servicePost a job


    Company info:

  • 101-250
  • 2013
  • Cambridge, MA
  • 100-500M



Claim company profile

About company:

AlloVir focuses on designing treatments for viral infections in immunocompromised patients with limited or no conventional treatment options. Their platform utilizes virus-specific T cells (VSTs) from healthy donors to confer immunity to patients with T cell deficiencies. AlloVir products are available off the shelf, with 11 potentially devastating viruses currently targeted for treatment with VST technology.

AlloVir creates VSTs by identifying viral antigens that produce robust T cell responses. Donors are screened and PBMCs are harvested and stimulated with peptide libraries targeting viral antigens. Promising candidates are selected and expanded while ensuring polyclonal populations. These virus-specific T cells are then cryopreserved and available off the shelf.


Claim company profile to post jobs directly on this page and this website.

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com